Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
CanSino Biologics Inc. clinical trials
The registry lists 41 studies whose lead sponsor is CanSino Biologics Inc.. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 8, 2026.
Keep track of what changes. Save the CanSino Biologics Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to CanSino Biologics Inc..
- CanSino Biologics Inc.41 studiesSame company
Something wrong?
Focus areas
Conditions CanSino Biologics Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 41 of 41.
- Observation of Immune Persistence in a Clinical Trial of an Adsorbed Tetanus VaccineNot yet recruitingNCT07807033
- Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)RecruitingNCT07600983Phase 1/2
- A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)Not yet recruitingNCT07648641
- A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined VaccineNot yet recruitingNCT07744347
- A Clinical Trial of the ACYW135 Group Meningococcal Polysaccharide-Conjugated Vaccine (CRM197 Vector)Not yet recruitingNCT07743411
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined VaccineRecruitingNCT07203755Phase 1
- A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)CompletedNCT06708286Phase 2/3
- Clinical Study of the Safety of Menhycia® in 3-Month-Old InfantsCompletedNCT06389513Phase 4
- A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)CompletedNCT06056050Phase 1
- A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year OldsCompletedNCT06700148Phase 3
- A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 YearsCompletedNCT06131554Phase 3
- A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and ToddlersActive, not recruitingNCT06577298Phase 1/2
- Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate VaccineActive, not recruitingNCT06621654Phase 1
- A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)Active, not recruitingNCT07017777Phase 3
- A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and OverCompletedNCT06120751Phase 3
- A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 YearsActive, not recruitingNCT06732583Phase 1
- Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)Active, not recruitingNCT05935176Phase 4
- Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineActive, not recruitingNCT06857370Phase 3
- A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year OldsActive, not recruitingNCT06226714Phase 3
- A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old PopulationCompletedNCT06011200Phase 3
- A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)Active, not recruitingNCT05951725Phase 3
- A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy AdultsCompletedNCT06101173Phase 1
- A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 YearsCompletedNCT05991427Phase 1
- Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and OlderCompletedNCT05373472Phase 2
- Clinical Trial of Recombinant Pneumococcal Protein VaccineCompletedNCT05622942Phase 1
- Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and OlderCompletedNCT05373485Phase 1
- A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and OverCompletedNCT06123663Phase 1
- Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)CompletedNCT04841369Phase 3
- IH Convidecia as Second Booster Dose Against Breakthrough InfectionsCompletedNCT05517642Phase 3
- A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 VaccineWithdrawnNCT05442684Phase 3
- Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)WithdrawnNCT05124561Phase 3
- A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and AdolescentsTerminatedNCT05169008Phase 3
- Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and AboveCompletedNCT04526990Phase 3
- Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for InhalationCompletedNCT04840992Phase 1/2
- A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.CompletedNCT04916886Not applicable
- Phase Ⅰa Clinical Trial of a Pneumococcal VaccineCompletedNCT04087460Early Phase 1
- Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and AboveCompletedNCT04100772Phase 1
- Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .CompletedNCT04099303Phase 1
- A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)CompletedNCT04566770Phase 2
- Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy AdultsCompletedNCT04313127Phase 1
- Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in CanadaStatus unknownNCT04398147Phase 1/2